Kentaro Hashimoto

发表

Nitrous Oxide Oxidation of Olefins Catalyzed by Ruthenium Porphyrin Complexes

Tohru Yamada, Kentaro Hashimoto, Yasunori Kitaichi, 2001 .

Design and synthesis of potent inhibitor of apoptosis (IAP) proteins antagonists bearing an octahydropyrrolo[1,2-a]pyrazine scaffold as a novel proline mimetic.

T. Kojima, M. Yabuki, Sei Yoshida, 2013, Journal of medicinal chemistry.

Antitumor Activity and Pharmacodynamic Biomarkers of a Novel and Orally Available Small-Molecule Antagonist of Inhibitor of Apoptosis Proteins

M. Yabuki, Sei Yoshida, T. Ishikawa, 2012, Molecular Cancer Therapeutics.

Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 1: Benzimidazole-5-sulfonamides.

Noriyuki Yamamoto, Takeshi Yura, Kentaro Hashimoto, 2005, Bioorganic & medicinal chemistry letters.

Design, synthesis, and biological activities of novel hexahydropyrazino[1,2-a]indole derivatives as potent inhibitors of apoptosis (IAP) proteins antagonists with improved membrane permeability across MDR1 expressing cells.

M. Yabuki, Sei Yoshida, T. Ishikawa, 2013, Bioorganic & medicinal chemistry.

Design, stereoselective synthesis, and biological evaluation of novel tri-cyclic compounds as inhibitor of apoptosis proteins (IAP) antagonists.

C. Mol, M. Yabuki, Sei Yoshida, 2013, Bioorganic & medicinal chemistry.

T-3256336, a novel and orally available small molecule IAP antagonist, induced tumor cell death via induction of systemic TNF alpha production.

M. Yabuki, Sei Yoshida, T. Ishikawa, 2016, Biochemical and biophysical research communications.

Nitrous oxide oxidation catalyzed by ruthenium porphyrin complex

Tohru Yamada, Kentaro Hashimoto, Yasunori Kitaichi, 2004 .

Selective nitrous oxide oxidation for C-H oxidation and aromatization of 9,10-dihydroanthracene derivatives

Tohru Yamada, Kentaro Hashimoto, T. Ikeno, 2002 .

Benzimidazole-5-sulfonamides as novel nonpeptide luteinizing hormone releasing hormone (LHRH) antagonists: minimization of mechanism-based CYP3A4 inhibition.

Yingfu Li, Kayo Yasoshima, Kentaro Hashimoto, 2005, Chemical & pharmaceutical bulletin.

Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 2: Benzimidazole-5-sulfonamides.

Noriyuki Yamamoto, Takeshi Yura, Kentaro Hashimoto, 2005, Bioorganic & medicinal chemistry letters.

An inhibitor of apoptosis protein antagonist T-3256336 potentiates the antitumor efficacy of the Nedd8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924).

Peter G. Smith, M. Yabuki, Sei Yoshida, 2016, Biochemical and biophysical research communications.

Novel, selective indole-based ECE inhibitors: lead optimization via solid-phase and classical synthesis.

J. Stasch, Kentaro Hashimoto, S. Siegel, 2005, Bioorganic & medicinal chemistry letters.

Remote Electronic Effect of Chiral N-Heterocyclic Carbene Catalyst on an Asymmetric Benzoin Reaction.

Kentaro Hashimoto, Ken‐ichi Yamada, T. Inokuma, 2023, Chemistry.